StockData
QIAGEN N.V. logo

QIAGEN N.V. (QGEN) stock

QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 10/30
$49.75−0.06 (-0.12%)

Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%

Qiagen operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2025 it was 22.3%, against 4.9% the year before. The highest annual figure on record is 28.0% in fiscal 2021.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202522.3%+17.4
FY2024Dec 31, 20244.9%−15.9
FY2023Dec 31, 202320.9%−4.0
FY2022Dec 31, 202224.8%−3.2
FY2021Dec 31, 202128.0%+7.3
FY2020Dec 31, 202020.7%+22.4
FY2019Dec 31, 2019-1.7%−19.5
FY2018Dec 31, 201817.8%+6.9
FY2017Dec 31, 201710.8%+3.4
FY2016Dec 31, 20167.4%−6.6
FY2015Dec 31, 201514.0%+2.0
FY2014Dec 31, 201412.0%+7.2
FY2013Dec 31, 20134.9%−8.7
FY2012Dec 31, 201213.5%+5.0
FY2011Dec 31, 20118.5%−8.8
FY2010Dec 31, 201017.3%−0.5
FY2009Dec 31, 200917.8%+1.5
FY2008Dec 31, 200816.3%–

More Qiagen figures

See a number that looks wrong?